Project and partnerships
Collaboration between research infrastructures
As part of the Slovak national ELIXIR node, we develop collaboration with complementary research infrastructures:
● ELIXIR – tools, workflows, data standards and training
● BBMRI.sk – biological samples and associated clinical data
● EATRIS-SK – translational medical research and connections between basic research and clinical applications.
● SLOVACRIN – preparation and support of academic clinical trials and international clinical research.
● EOSC – data and computing capacities, interoperability and federated analysis.
Two memoranda confirm this collaboration:
● between ELIXIR NODE SK, BBMRI.sk, EATRIS-SK and SLOVACRIN on connecting biomedical research infrastructures (memorandum dated 23 September 2026).
● with CVTI SR on establishing the EOSC SK node
Academic, clinical and industrial collaboration
We collaborate with academic, clinical and technology institutions to develop and validate methods. Collaboration with industrial partners connects research and translational expertise. National partnerships are complemented by international contacts and joint publications, expanding opportunities for research and validation of results.
Training and the scientific community
We organise and co-organise professional courses, workshops and scientific meetings. Practical training connects laboratory work with bioinformatics; conference activities provide opportunities for scientific discussion and new collaborations. Information about upcoming events is published through Comenius University Science Park’s communication channels.
Projects undertaken
International infrastructures
ELIXIR Slovakia — since 15 December 2025 | Coordinator of the Slovak national ELIXIR node | A distributed infrastructure connecting biological data, bioinformatics tools, services and training.
International projects
FORGENOM II — 01.05.2024 – 30.04.2027 | 101160008. Development of Comenius University’s research profile in genomics, bioinformatics and proteomics through collaboration with international institutions.
PANGAIA — 01.01.2020 – 31.10.2025 | 872539. Investigates graph representations of genome collections as an alternative to conventional sequence representations.
ALPACA — 2021–2024 | 956229. Research into computational approaches for pangenomes, combined with training a new generation of researchers.
BY-COVID — 01.10.2021 – 30.09.2024 | 101046203. European collaboration on the accessibility and integration of infectious disease data.
National projects and activities
GenSafe — 07/2025 – 12/2029 | 401101C603. Connects genomic data resources from human, food and environmental domains, with a focus on pathogens and AMR.
DIGI-PATH — 03/2024 – 08/2026 | 09I05-03-V02-00059. Development of a system using genomic data on human pathogens.
EXAMINER-FM — 01/2025 – 06/2026 | 09I01-03-V04-00085. Additional research support building on funding obtained through European framework programmes.
BLAC-GPRO — 01.05.2024 – 30.06.2026 | 09I03-03-V03-00046. Research into genetic variation in bladder tumours.
National COVID-19 sequencing — 2022–2024. Genomic surveillance of SARS-CoV-2 variants, including laboratory sequencing, data processing and a national information system.
PreveLynch — 01/2020 – 06/2023 | 313011V578. Research into the prevalence of Lynch syndrome and prevention of associated cancers in the Slovak population.
SANET / SANET2 — 06/2020 – 06/2023 | 313011W988. Research into the use of network infrastructure; the team’s source material specifies efficient processing of large, specialised datasets.
PanClinCov — 09/2020 – 06/2023 | 313011ATL7. Combines viral genome characterisation with analysis of the human exome during infection.
LISPER — 09/2019 – 06/2023 | 313011V446. An integrated approach to personalised medicine for selected cancers.
APVV projects
GenoMicrosat 2 — 01.09.2025 – 31.08.2029 | APVV-24-0284. Further development of STR analysis from modern sequencing data, including large WGS datasets and complex loci.
GESTALT — 01.03.2025 – 30.06.2028 | VV-MVP-24-0290. Connecting the analysis of hereditary and tumour mutations in Lynch syndrome.
INHALE — 01.07.2024 – 30.06.2027 | APVV-23-0520. Investigates exhaled breath condensate as material for genomic testing of lung cancer and the use of machine learning.
DoHumNA — 01.07.2024 – 30.06.2027 | APVV-23-0601. Development of a depletion kit to separate human DNA from mixtures containing pathogen DNA, including challenging and fragmented samples.
INCAM — 01.07.2022 – 30.06.2026 | APVV-21-0296. Research into biomarkers associated with colorectal cancer recurrence after metastasis removal.
DRPGE — 01.07.2022 – 30.06.2026 | APVV-21-0210. Basic research into the relationship between DNA repair and gene expression regulation in a yeast model.
GenoMicrosat 1 — 01.07.2019 – 30.06.2023 | APVV-18-0319. Development of methods for analysing short tandem repeats (STRs) in sequencing data. Model applications include hereditary repeat expansion disorders and Lynch syndrome.
NECROCOV — 2020 – 2022 | PP-COVID-20-0051. Research into causes of death in COVID-19, incorporating genomic analysis.
Dbl2 — 07/2019 – 06/2022 | APVV-18-0219. Basic research into genome regulation and maintenance in a yeast model.
Winezymes — 01.07.2017 – 30.06.2020 | APVV-16-0264. Investigates the use of microbial communities to optimise wine fermentation.
NEXTVIR — 01.07.2016 – 30.06.2019 | APVV-15-0232. Development of methods for sequencing and bioinformatics evaluation of viruses in host samples.

